| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.009 |